[HTML][HTML] SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature, 2021 - nature.com
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape,–, have activity
against diverse sarbecoviruses,,–, and be highly protective through viral neutralization,,–and …

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta… - …, 2021 - pubmed.ncbi.nlm.nih.gov
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape 1-3, have activity
against diverse sarbecoviruses 4-7, and be highly protective through viral neutralization 8 …

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature, 2021 - escholarship.org
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1-3, have activity
against diverse sarbecoviruses4-7, and be highly protective through viral neutralization8-11 …

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - …, 2021 - ui.adsabs.harvard.edu
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape 1-3, have activity
against diverse sarbecoviruses 4-7, and be highly protective through viral neutralization 8 …

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature, 2021 - econpapers.repec.org
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1–3, have activity
against diverse sarbecoviruses4–7, and be highly protective through viral neutralization8 …

[HTML][HTML] SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature, 2021 - ncbi.nlm.nih.gov
An ideal anti-SARS-CoV-2 antibody would resist viral escape 1–3, have activity against
diverse SARS-related coronaviruses (sarbecoviruses) 4–7, and be highly protective through …

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature, 2021 - profiles.wustl.edu
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape 1–3, have activity
against diverse sarbecoviruses 4–7, and be highly protective through viral neutralization 8 …

[引用][C] SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature, 2021 - cir.nii.ac.jp
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.

TN Starr, N Czudnochowskina, Z Liu, F Zatta, YJ Park… - 2021 - cabidigitallibrary.org
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape, have activity
against diverse sarbecoviruses, and be highly protective through viral neutralization and …

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature (London), 2021 - osti.gov
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1, 2, 3, have
activity against diverse sarbecoviruses4, 5, 6, 7, and be highly protective through viral …